Key result
Sirolimus-eluting stent triggers STEMI from very late stent thrombosis 11 years post-implantation.
Why the study?
Very late stent thrombosis is an infrequent but potentially fatal complication with drug-eluting stents, and the optimal duration of antiplatelet therapy remains uncertain.
Case Report (n=1)
This case highlights the risk of very late stent thrombosis occurring more than a decade after drug-eluting stent implantation, raising questions about optimal antiplatelet therapy duration.
Answers are grounded in this paper and cite their sources.
Alerts to very late thrombosis risk after DES; leaves open optimal antiplatelet duration.
Very late stent thrombosis is an infrequent yet potentially fatal complication associated with drug-eluting stents. We report the case of an 88-year-old man who sustained an ST-segment-elevation myocardial infarction 11 years after initial sirolimus-eluting stent implantation. Optical coherence tomograms of the lesion showed that the focal incomplete endothelialization of the stent struts was the likely cause; neointimal formation, neoatherosclerosis, and late stent malapposition might also have contributed. To our knowledge, this is the longest reported intervening period between stent insertion and the development of an acute coronary event secondary to very late stent thrombosis. The associated prognostic and therapeutic implications are considerable, because they illuminate the uncertainties surrounding the optimal duration of antiplatelet therapy in patients who have drug-eluting stents. Clinicians face challenges in treating these patients, particularly when competing medical demands necessitate the discontinuation of antiplatelet therapy. In addition to the patient's case, we discuss factors that can contribute to very late stent thrombosis.
No takes yet. Share an insight, caveat, or question.
Liou et al. (2015) conducted a case report in Very late stent thrombosis / ST-segment-elevation myocardial infarction (n=1). Sirolimus-eluting stent was evaluated on Very late stent thrombosis. An 88-year-old man developed an ST-segment-elevation myocardial infarction due to very late stent thrombosis 11 years after receiving a sirolimus-eluting stent.
Synapse has enriched 10 related papers. Consider them for comparative context: